Results 231 to 240 of about 86,298 (291)
DigestionSome of the next articles are maybe not open access.
Related searches:
Related searches:
Mayo Clinic Proceedings, 1983
Metronidazole, a nitroimidazole derivative, is a unique antimicrobial agent that is active against both bacterial and parasitic organisms, although only the anaerobic members of these groups are susceptible. It has been used for the treatment of trichomoniasis for about 20 years and is also effective against amebiasis and giardiasis.
J E, Rosenblatt, R S, Edson
openaire +4 more sources
Metronidazole, a nitroimidazole derivative, is a unique antimicrobial agent that is active against both bacterial and parasitic organisms, although only the anaerobic members of these groups are susceptible. It has been used for the treatment of trichomoniasis for about 20 years and is also effective against amebiasis and giardiasis.
J E, Rosenblatt, R S, Edson
openaire +4 more sources
Obstetrics and Gynecology Clinics of North America, 1992
Metronidazole has proven to be a useful and inexpensive antibiotic for the treatment of T. vaginalis and bacterial vaginosis. Few alternatives exist for these two specific indications, and metronidazole will continue to play a primary role in therapy. Oral metronidazole continues to be a very inexpensive alternative to oral vancomycin for the treatment
W D, Hager, R P, Rapp
openaire +2 more sources
Metronidazole has proven to be a useful and inexpensive antibiotic for the treatment of T. vaginalis and bacterial vaginosis. Few alternatives exist for these two specific indications, and metronidazole will continue to play a primary role in therapy. Oral metronidazole continues to be a very inexpensive alternative to oral vancomycin for the treatment
W D, Hager, R P, Rapp
openaire +2 more sources
Journal of Pharmaceutical Sciences, 1969
The literature on the identification, assay, and use of metronidazole has been surveyed. Based on published information, private communications, and laboratory experimentation, qualitative tests and quantitative assays have been developed for metronidazole, metronidazole suppositories (vaginal tablets), and metronidazole tablets.
M M, Tuckerman, T, Bićan-Fister
openaire +2 more sources
The literature on the identification, assay, and use of metronidazole has been surveyed. Based on published information, private communications, and laboratory experimentation, qualitative tests and quantitative assays have been developed for metronidazole, metronidazole suppositories (vaginal tablets), and metronidazole tablets.
M M, Tuckerman, T, Bićan-Fister
openaire +2 more sources
Medical Clinics of North America, 1988
Metronidazole is a highly effective therapy for anaerobic infections and a variety of protozoal and parasitic diseases. Its pharmacokinetics, toxicities, and unique mode of action are reviewed in detail. Indications for use and respective dosages are suggested.
openaire +2 more sources
Metronidazole is a highly effective therapy for anaerobic infections and a variety of protozoal and parasitic diseases. Its pharmacokinetics, toxicities, and unique mode of action are reviewed in detail. Indications for use and respective dosages are suggested.
openaire +2 more sources
Infection Control, 1986
Metronidazole was introduced to the market in 1959 as the only effective therapy forTrichomonas vaginalis. A nitroimidazole derivative, its success in the therapy of parasitic infections, includingEntamoeba histolyticaandGiardia lamblia, has been well documented.
openaire +3 more sources
Metronidazole was introduced to the market in 1959 as the only effective therapy forTrichomonas vaginalis. A nitroimidazole derivative, its success in the therapy of parasitic infections, includingEntamoeba histolyticaandGiardia lamblia, has been well documented.
openaire +3 more sources
Annals of Internal Medicine, 1980
Metronidazole is currently approved for use against Trichomonas infection and amebiasis. It is also effective against giardiasis, "nonspecific vaginitis," and anaerobic infections and bactericidal against almost all obligately anaerobic organisms; Actinomyces, Arachnia, and Propionibacterium are exceptions.
openaire +2 more sources
Metronidazole is currently approved for use against Trichomonas infection and amebiasis. It is also effective against giardiasis, "nonspecific vaginitis," and anaerobic infections and bactericidal against almost all obligately anaerobic organisms; Actinomyces, Arachnia, and Propionibacterium are exceptions.
openaire +2 more sources